These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8867916)

  • 1. Naloxonazine antagonism of levorphanol-induced antinociception and respiratory depression in rhesus monkeys.
    Gatch MB; Liguori A; Negus SS; Mello NK; Bergman J
    Eur J Pharmacol; 1996 Feb; 298(1):31-6. PubMed ID: 8867916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.
    Gatch MB; Negus SS; Mello NK; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1282-9. PubMed ID: 8819513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism by naloxone of narcotic-induced respiratory depression and analgesia.
    McGilliard KL; Takemori AE
    J Pharmacol Exp Ther; 1978 Nov; 207(2):494-503. PubMed ID: 30841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
    Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonist effects of beta-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat.
    Negus SS; Pasternak GW; Koob GF; Weinger MB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):739-45. PubMed ID: 8437122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and beta-funaltrexamine.
    Negus SS; Brandt MR; Gatch MB; Mello NK
    Drug Alcohol Depend; 2003 May; 70(1):17-27. PubMed ID: 12681522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic effects of naloxone and naloxonazine on sufentanil-induced antinociception and respiratory depression in rats.
    Verborgh C; Meert TF
    Pain; 1999 Oct; 83(1):17-24. PubMed ID: 10506668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys.
    Butelman ER; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1996 Nov; 279(2):934-8. PubMed ID: 8930202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
    Walker EA; Butelman ER; DeCosta BR; Woods JH
    J Pharmacol Exp Ther; 1993 Oct; 267(1):280-6. PubMed ID: 7901396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone.
    Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Zadina JE; Kastin AJ; Sakurada T
    Brain Res; 2000 Oct; 881(1):1-8. PubMed ID: 11033087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory effects of opioid full and partial agonists in rhesus monkeys.
    Liguori A; Morse WH; Bergman J
    J Pharmacol Exp Ther; 1996 Apr; 277(1):462-72. PubMed ID: 8613955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys.
    Butelman ER; Winger G; Zernig G; Woods JH
    J Pharmacol Exp Ther; 1995 Feb; 272(2):845-53. PubMed ID: 7853203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
    Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
    Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive effect of dihydroetorphine in diabetic mice.
    Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermorphin analog Tyr-D-Arg2-Phe-sarcosine-induced opioid analgesia and respiratory stimulation: the role of mu 1-receptors?
    Paakkari P; Paakkari I; Vonhof S; Feuerstein G; Sirén AL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):544-50. PubMed ID: 8394909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys.
    Bowen CA; Fischer BD; Mello NK; Negus SS
    J Pharmacol Exp Ther; 2002 Jul; 302(1):264-73. PubMed ID: 12065726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
    Bertalmio AJ; Woods JH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):591-7. PubMed ID: 2824753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
    Heyman JS; Williams CL; Burks TF; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1988 Apr; 245(1):238-43. PubMed ID: 2834537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.